U.S. v. 2035 INC.

No. 5:14-CV-05075-KES.

UNITED STATES OF AMERICA, Plaintiff, v. 2035 INC., a corporation, and ROBERT L. LYTLE, an individual d/b/a 2035 PMA and QLASERS PMA, Defendants.

United States District Court, D. South Dakota, Western Division.

May 4, 2017.

Editors Note
Applicable Law: 21 U.S.C. § 842
Cause: 21 U.S.C. § 842 Food & Drugs - Prohibited Acts
Nature of Suit: 890 Other Statutes: Other Statutory Actions
Source: PACER


Attorney(s) appearing for the Case

United States of America, Plaintiff, represented by Camela C. Theeler , U.S. Attorney's Office.

United States of America, Plaintiff, represented by Ann F. Entwistle , U.S. Department of Justice & Sonia W. Nath , U.S. Food and Drug Administration.

Robert L. Lytle, an individual doing business as 2035 PMA doing business as QLasers PMA, Defendant, Pro Se.


MEMORANDUM OPINION AND ORDER

This matter is before the court following the recusal of Chief Judge Jeffrey L. Viken from any further participation in this matter. Docket 167. Currently pending are nine motions filed by pro se defendant Robert L. Lytle, and one motion filed by plaintiff, the United...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases